Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Labor, Obstetric | 4 | 2024 | 38 | 2.700 |
Why?
|
| Pregnancy | 25 | 2024 | 2213 | 2.290 |
Why?
|
| Delivery, Obstetric | 5 | 2024 | 51 | 2.210 |
Why?
|
| Oligohydramnios | 2 | 2024 | 2 | 1.720 |
Why?
|
| Depression, Postpartum | 5 | 2024 | 131 | 1.450 |
Why?
|
| Parturition | 5 | 2024 | 52 | 1.420 |
Why?
|
| Abortion, Habitual | 2 | 2020 | 8 | 1.410 |
Why?
|
| Fetal Growth Retardation | 3 | 2024 | 14 | 1.270 |
Why?
|
| Postpartum Period | 4 | 2024 | 187 | 1.170 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2024 | 39 | 1.050 |
Why?
|
| Pregnancy Outcome | 5 | 2024 | 181 | 0.900 |
Why?
|
| Obstetrics | 2 | 2024 | 80 | 0.900 |
Why?
|
| Labor, Induced | 2 | 2023 | 25 | 0.900 |
Why?
|
| Pregnancy Complications | 3 | 2023 | 364 | 0.900 |
Why?
|
| Loeys-Dietz Syndrome | 1 | 2024 | 4 | 0.900 |
Why?
|
| Anxiety | 3 | 2024 | 387 | 0.890 |
Why?
|
| Female | 28 | 2024 | 30726 | 0.890 |
Why?
|
| Marfan Syndrome | 1 | 2024 | 17 | 0.880 |
Why?
|
| Chorionic Gonadotropin | 1 | 2023 | 14 | 0.880 |
Why?
|
| Uterus | 2 | 2020 | 39 | 0.870 |
Why?
|
| Infant, Newborn | 8 | 2024 | 1284 | 0.860 |
Why?
|
| Contraception | 1 | 2024 | 67 | 0.850 |
Why?
|
| Contraceptive Agents, Female | 1 | 2023 | 24 | 0.850 |
Why?
|
| Smoking Water Pipes | 1 | 2023 | 6 | 0.830 |
Why?
|
| Tobacco, Waterpipe | 1 | 2023 | 8 | 0.830 |
Why?
|
| Body Mass Index | 2 | 2023 | 831 | 0.810 |
Why?
|
| Oxytocics | 1 | 2022 | 14 | 0.800 |
Why?
|
| Premature Birth | 2 | 2021 | 108 | 0.800 |
Why?
|
| Breast Feeding | 1 | 2024 | 144 | 0.770 |
Why?
|
| Metformin | 1 | 2021 | 64 | 0.700 |
Why?
|
| Hysteroscopy | 1 | 2020 | 3 | 0.700 |
Why?
|
| Medicaid | 1 | 2024 | 353 | 0.680 |
Why?
|
| Physicians | 2 | 2024 | 440 | 0.670 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2024 | 381 | 0.670 |
Why?
|
| Diabetes, Gestational | 1 | 2021 | 138 | 0.640 |
Why?
|
| Humans | 28 | 2024 | 59389 | 0.610 |
Why?
|
| Inpatients | 1 | 2021 | 292 | 0.600 |
Why?
|
| Gestational Age | 3 | 2024 | 178 | 0.590 |
Why?
|
| Cesarean Section | 3 | 2024 | 95 | 0.590 |
Why?
|
| Depression | 3 | 2023 | 829 | 0.580 |
Why?
|
| Adult | 10 | 2024 | 15681 | 0.510 |
Why?
|
| Retrospective Studies | 6 | 2024 | 6071 | 0.480 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2021 | 635 | 0.470 |
Why?
|
| Prospective Studies | 4 | 2023 | 3067 | 0.360 |
Why?
|
| Cross-Sectional Studies | 2 | 2023 | 2382 | 0.260 |
Why?
|
| Nausea | 2 | 2023 | 110 | 0.240 |
Why?
|
| Vomiting | 2 | 2023 | 133 | 0.240 |
Why?
|
| Gynecology | 1 | 2024 | 50 | 0.230 |
Why?
|
| Young Adult | 2 | 2024 | 4272 | 0.220 |
Why?
|
| Rhode Island | 1 | 2024 | 98 | 0.220 |
Why?
|
| Pregnancy Complications, Cardiovascular | 1 | 2024 | 31 | 0.220 |
Why?
|
| Hospitals, Community | 1 | 2024 | 70 | 0.220 |
Why?
|
| Apgar Score | 1 | 2023 | 11 | 0.210 |
Why?
|
| Resuscitation | 1 | 2024 | 70 | 0.210 |
Why?
|
| Prostaglandins | 1 | 2022 | 17 | 0.210 |
Why?
|
| Mood Disorders | 1 | 2023 | 69 | 0.200 |
Why?
|
| Placenta | 1 | 2022 | 55 | 0.200 |
Why?
|
| Oxytocin | 1 | 2022 | 45 | 0.200 |
Why?
|
| Antiemetics | 1 | 2023 | 95 | 0.200 |
Why?
|
| Academic Medical Centers | 1 | 2024 | 308 | 0.190 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2024 | 692 | 0.190 |
Why?
|
| Mass Screening | 2 | 2024 | 648 | 0.190 |
Why?
|
| Patient Care Team | 1 | 2024 | 327 | 0.190 |
Why?
|
| Embryo Loss | 1 | 2020 | 10 | 0.180 |
Why?
|
| Parity | 1 | 2021 | 70 | 0.180 |
Why?
|
| Prevalence | 1 | 2024 | 1253 | 0.180 |
Why?
|
| Live Birth | 1 | 2020 | 20 | 0.170 |
Why?
|
| Surveys and Questionnaires | 2 | 2024 | 2516 | 0.170 |
Why?
|
| Hydroxyprogesterones | 1 | 2019 | 6 | 0.170 |
Why?
|
| Weight Loss | 1 | 2021 | 263 | 0.160 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 483 | 0.150 |
Why?
|
| Fetal Diseases | 1 | 2017 | 21 | 0.140 |
Why?
|
| Blood Gas Analysis | 1 | 2017 | 34 | 0.140 |
Why?
|
| Acidosis | 1 | 2017 | 26 | 0.140 |
Why?
|
| Fetal Blood | 1 | 2017 | 70 | 0.140 |
Why?
|
| Administrative Personnel | 1 | 2017 | 29 | 0.140 |
Why?
|
| Posture | 1 | 2017 | 127 | 0.130 |
Why?
|
| Opioid-Related Disorders | 1 | 2023 | 456 | 0.130 |
Why?
|
| Emergency Service, Hospital | 1 | 2024 | 1022 | 0.130 |
Why?
|
| Occupational Health | 1 | 2017 | 181 | 0.120 |
Why?
|
| Walking | 1 | 2017 | 228 | 0.120 |
Why?
|
| United States | 2 | 2024 | 7426 | 0.110 |
Why?
|
| Adolescent | 1 | 2024 | 5838 | 0.110 |
Why?
|
| Health Promotion | 1 | 2017 | 471 | 0.100 |
Why?
|
| Middle Aged | 2 | 2024 | 16314 | 0.080 |
Why?
|
| Pilot Projects | 2 | 2023 | 914 | 0.070 |
Why?
|
| Male | 2 | 2024 | 27749 | 0.060 |
Why?
|
| Prescriptions | 1 | 2023 | 30 | 0.050 |
Why?
|
| Perinatal Care | 1 | 2024 | 59 | 0.050 |
Why?
|
| Capsaicin | 1 | 2023 | 22 | 0.050 |
Why?
|
| Perception | 1 | 2024 | 168 | 0.050 |
Why?
|
| Prenatal Care | 1 | 2023 | 170 | 0.050 |
Why?
|
| Emergency Medicine | 1 | 2024 | 182 | 0.050 |
Why?
|
| Anxiety Disorders | 1 | 2023 | 186 | 0.050 |
Why?
|
| Pain | 1 | 2023 | 396 | 0.040 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 678 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 602 | 0.040 |
Why?
|
| Interior Design and Furnishings | 1 | 2017 | 3 | 0.040 |
Why?
|
| Leisure Activities | 1 | 2017 | 25 | 0.040 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2017 | 450 | 0.030 |
Why?
|
| Sleep | 1 | 2017 | 215 | 0.030 |
Why?
|
| Obesity | 1 | 2019 | 1166 | 0.020 |
Why?
|
| Time Factors | 1 | 2017 | 3617 | 0.020 |
Why?
|